Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026
Business Wire•20/10/2026•08:00 ET
0
Key Highlights
- ➤Scholar Rock will report Q3 2026 financial results November 10 before markets open
- ➤Conference call and webcast with Scholar Rock management scheduled for 8:00 a.m. ET
- ➤FDA approved ISEMBLYD (apitegromab-mstn) in September 2026
- ➤Scholar Rock is commercializing ISEMBYLD for U.S. SMA patients aged two and older
- ➤Company plans to expand ISEMBYLD access globally in up to 50 countries
Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026
Scholar Rock (NASDAQ: SRRK) today announced that it will report third quarter 2026 financial results on Tuesday, November 10, 2026, before the financial markets open.
Get started
Create a free account to read the full story.